Note: Ingredients listed on restricted chemical lists
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
N/A
General Information
Revision date
2022-03-04
Product name
AUGMENTIN 7:1 ORAL SUSPENSION POWDER IN BOTTLE
Product Synonyms
AUGMENTIN DUO 200/28.5 MG/5 ML * AUGMENTIN DUO 400/57 MG/5 ML * AUGMENTIN 200
1.2.2. Uses advised against
No other uses are advised
supplier name
GlaxoSmithKline UK
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
result in GHS classification: 2.1 GHS classification of substance or mixture, and national or regional information
Physical hazards
Not classified.
Health hazards
Sensitization, respiratory Category 1 Sensitization, skin Category 1
Environmental hazards
Not classified.
2.2 Label elements
Hazard symbol(s)
Signal word
Danger
Hazard statements
May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
Avoid breathing dust. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves. In case of inadequate ventilation wear respiratory protection.
Response
IF ON SKIN Wash with plenty of soap and water. IF INHALED If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. If skin irritation or rash occurs Get medical advice/attention. If experiencing respiratory symptoms Call a POISON CENTRE or doctor/physician. Wash contaminated clothing before reuse.
Disposal
Dispose of contents/container (in accordance with related regulations). 2.3 Other hazards which do not This product will support combustion. May form explosible dust-air mixture if dispersed. result in GHS classification Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
35.99 % of the mixture consists of component(s) of unknown acute oral toxicity. 35.99 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99.18 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 97.32 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
